Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of vildagliptin versus placebo on the incretin effect in metformin-treated patients with Type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED